SCHEMBL7150338

SCHEMBL7150338

Cc1nc2scc(C)n2c(=O)c1CCN1CCC(n2ccc3ccccc32)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.51
SLC6A4 P31645 2/20 0.51
HTR2A P28223 5/20 0.43
HTR7 P34969 2/20 0.43
HTR1A P08908 5/20 0.40
KDM4E B2RXH2 4/20 0.40
HPGD P15428 3/20 0.40
CYP2D6 P10635 3/20 0.40
MAPT P10636 3/20 0.40
TSHR P16473 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
KMT2A Q03164 3/20 0.40
HTR2C P28335 3/20 0.40
MEN1 O00255 2/20 0.40
CYP3A4 P08684 2/20 0.40
PKM P14618 2/20 0.40
PMP22 Q01453 2/20 0.40
THPO P40225 1/20 0.40
ALDH1A1 P00352 4/20 0.38
HSD17B10 Q99714 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7147314 0.84 CYP2D6 (0.54) DRD2SLC6A4HTR2AHTR7HTR1A
SCHEMBL7149529 0.80 DRD2 (0.53) DRD2SLC6A4HTR2AHTR7HTR1A
SCHEMBL7145335 0.79 DRD2 (0.52) DRD2SLC6A4HTR2AHTR7HTR1A
SCHEMBL8477986 0.79 DRD2 (0.44) DRD2SLC6A4HTR2AHTR7KDM4E
SCHEMBL12786170 0.75 DRD2 (0.48) DRD2HTR2AHTR1AKDM4EHPGD
SCHEMBL10922355 0.74 HTR2A (0.44) DRD2HTR2AHTR1AKDM4EHPGD
SCHEMBL10922929 0.74 ADRA1D (0.48) DRD2SLC6A4HTR2AHTR7HTR1A
SCHEMBL10600681 0.74 ALDH1A1 (0.64) DRD2SLC6A4HTR2AHTR7HTR1A
SCHEMBL10922904 0.73 HTR2C (0.64) DRD2SLC6A4HTR2AHTR7HTR1A
SCHEMBL7142123 0.73 HTR2A (0.59) DRD2SLC6A4HTR2AHTR7HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0808313-B1 ANTIPSYCHOTIC 4-(1H-INDOLYL-1-YL)-1-SUBSTITUTED PIPERIDINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2003-08-13 EP disclosed